PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Protein Aurora-A is found to be associated with survival in head and neck cancer

Fox Chase scientists suggest that the findings could also serve as a new target for treatment

2012-04-02
(Press-News.org) CHICAGO, IL (April 1, 2012)––Researchers at Fox Chase Cancer Center in Philadelphia have found that a protein associated with other cancers appears to also be important in head and neck cancer, and may consequently serve as a good target for new treatments. The findings will be reported at the AACR Annual Meeting 2012 on Sunday, April 1.

The researchers found that patients whose tumors had higher levels of the protein known as Aurora-A had a shorter survival following surgery to remove their tumors than patients whose tumors had normal levels of the protein.

"This finding suggests Aurora A does play a role in the development of head and neck cancers," says study author Christian J. Fidler, M.D., chief fellow in medical oncology at Fox Chase. "Consequently, Aurora-A represents another potential target for additional therapies."

Previous research has associated Aurora-A with other cancer types, such as genitourinary, gastrointestinal, breast and lung cancers. As a result, companies have developed compounds that target this protein, now being tested in clinical trials.

To test whether head and neck cancer patients might also benefit from compounds that target Aurora-A, Fidler and his colleagues studied cancer tissue removed from 89 patients at Fox Chase.

They found that some did, in fact, contain high levels of Aurora-A, suggesting the protein may have been helping to fuel the disease. Furthermore, after controlling for the size of the primary tumor, half of these patients lived 36 months or less, while those with normal levels of Aurora-A survived for 92 months. "In patients with high levels of Aurora-A, their survival was much worse," says Fidler.

Aurora-A is a type of kinase, a group of proteins which play an important role in cancer and other cellular processes. More specifically, Aurora-A helps carry out signals from a protein on the surface of the cell called EGFR, which help tell the cell to grow or divide. When that process becomes very activated, it can trigger cancer, says Fidler.

To really hit the brakes on this pathway, he says, doctors may want to test a combination of an inhibitor of Aurora-A and a drug already on the market that targets EGFR (cetuximab, Erbitux), after first identifying patients who over-express Aurora-A. "At some point, you may see a clinical trial that uses Aurora-A inhibitors in conjunction with cetuximab," he predicts.

"These findings identify another potential target for head and neck cancer therapy, which could potentially change the course of the disease," says Fidler.

INFORMATION:

Fidler's co-authors include Donghua Yang, Fang Zhu, Ranee Mehra, Igor Astsaturov, John Ridge, Erica Golemis, and Barbara Burtness, all at Fox Chase.

This work was funded by Fox Chase Cancer Center's Keystone Program in Head and Neck Cancer.

Fox Chase Cancer Center is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation's first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center's nursing program has received the Magnet status for excellence three consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, visit Fox Chase's Web site at www.foxchase.org or call 1-888-FOX CHASE or (1-888-369-2427).

END



ELSE PRESS RELEASES FROM THIS DATE:

The protein survivin could be a useful biomarker for pancreatic cancer

2012-04-02
CHICAGO, IL (April 1, 2012)––Pancreatic cancer kills more than 40,000 people every year, and among cancers it's particularly insidious. For 80 percent of patients, the disease is already so advanced at the time of diagnosis that treatment is unlikely to provide significantly life-extending benefits. For patients diagnosed with localized pancreatic cancer, the five-year survival rate remains barely above 20 percent, according to the National Cancer Institute. New research from scientists at Fox Chase Cancer Center in Philadelphia, which will be presented at the AACR Annual ...

Fox Chase scientists identify key protein players in hard-to-treat breast cancers

2012-04-02
CHICAGO, IL (April 1, 2012)––At the time of diagnosis, the majority of breast cancers are categorized as estrogen-receptor positive, or hormone sensitive, which means their cancerous cells may need estrogen to grow. Patients with this type of cancer often respond favorably to treatments called aromatase inhibitors, like tamoxifen, which cause cell death by preventing estrogen from reaching the cancerous cells. Over time, however, the disease often becomes resistant to estrogen deprivation from the drugs—making treatment options more limited. New findings that will be ...

New comparison of ocean temperatures reveals rise over the last century

2012-04-02
A new study contrasting ocean temperature readings of the 1870s with temperatures of the modern seas reveals an upward trend of global ocean warming spanning at least 100 years. The research led by Scripps Institution of Oceanography at UC San Diego physical oceanographer Dean Roemmich shows a .33-degree Celsius (.59-degree Fahrenheit) average increase in the upper portions of the ocean to 700 meters (2,300 feet) depth. The increase was largest at the ocean surface, .59-degree Celsius (1.1-degree Fahrenheit), decreasing to .12-degree Celsius (.22-degree Fahrenheit) at ...

Raising the school leaving – while learning from another age

2012-04-02
In April 1947 the post-war Labour Government raised the school leaving age from 14 to 15 and paved the way for a further increase to 16 in 1972. Now, 65 years later, as the UK prepares to raise the 'education participation age' to 17 in 2013 and to 18 in 2015, new research reveals that the transitions of 1947 and 1972 met with more controversy and difficulty than previously thought. In a study funded by the Economic and Social Research Council, Dr Tom Woodin and Professor Gary McCulloch of the Institute of Education, London, analysed the debate surrounding the implementation ...

Expert task force recommends halving global fishing for crucial prey species

Expert task force recommends halving global fishing for crucial prey species
2012-04-02
WASHINGTON – Fishing for herring, anchovy, and other "forage fish" in general should be cut in half globally to account for their critical role as food for larger species, recommends an expert group of marine scientists in a report released today. The Lenfest Forage Fish Task Force conducted the most comprehensive worldwide analysis of the science and management of forage fish populations to date. Its report, "Little Fish, Big Impact: Managing a crucial link in ocean food webs," concluded that in most ecosystems at least twice as many of these species should be left in ...

New discovery may lead to effective prevention and treatment of graft-versus-host dsease

2012-04-02
Bethesda, MD -- A new discovery in mice may lead to new treatments that could make bone marrow transplants more likely to succeed and to be significantly less dangerous. According to new research findings published in the Journal of Leukocyte Biology (https://www.jleukbio.org) Brazilian scientists may have found a way to prevent the immune system from attacking transplant grafts and damaging the host's own cells after a bone marrow transplant. Specifically, they found that a receptor for a mediator of the inflammatory process, known as platelet activating factor plays ...

Gene variations linked to intestinal blockage in newborns with cystic fibrosis

Gene variations linked to intestinal blockage in newborns with cystic fibrosis
2012-04-02
CHAPEL HILL, N.C. -- University of North Carolina at Chapel Hill researchers working as part of the International Cystic Fibrosis Consortium have discovered several regions of the genome that may predispose cystic fibrosis (CF) patients to develop an intestinal blockage while still in the uterus. A report of this international study appears online April 1, 2012 in the journal Nature Genetics. It was the work of the North America CF Gene Modifier Consortium, which brought together dozens of investigators from the United States, Canada, and from France, to identify genetic ...

Picky females promote diversity: UBC-IIASA study

2012-04-02
Picky females play a critical role in the survival and diversity of species, according to a Nature study by researchers from the University of British Columbia and the International Institute for Applied Systems Analysis (IIASA) in Austria. To date, biodiversity theories have focused on the role played by adaptations to the environment: the species best equipped to cope with a habitat would win out, while others would gradually go extinct. The new study presents the first theoretical model demonstrating that selective mating alone can promote the long-term coexistence ...

DNA sequencing lays foundation for personalized cancer treatment

DNA sequencing lays foundation for personalized cancer treatment
2012-04-02
Scientists at Washington University School of Medicine in St. Louis are using powerful DNA sequencing technology not only to identify mutations at the root of a patient's tumor – considered key to personalizing cancer treatment – but to map the genetic evolution of disease and monitor response to treatment. "We're finding clinically relevant information in the tumor samples we're sequencing for discovery-oriented research studies," says Elaine Mardis, PhD, co-director of The Genome Institute at the School of Medicine. "Genome analysis can play a role at multiple time ...

Los Angeles Personal Injury Lawyer, Farhad Hamdam, is Now Offering Representation for All Personal Injury Cases Involving Car Accidents

Los Angeles Personal Injury Lawyer, Farhad Hamdam, is Now Offering Representation for All Personal Injury Cases Involving Car Accidents
2012-04-02
Minor accidents take place every single day in Southern California. These ordeals can often be resolved with the assistance of an insurance company and a fair settlement that is going to quickly pay for injuries, damage to property, or any other associated costs. When drivers are not receiving the financial assistance that they need in order to pay for serious or ongoing medical expenses though, it will not take much for the situation to enhance into a messy legal situation. In order to assist victims, the leading Los Angeles personal injury lawyer, Farhad Hamdam, is now ...

LAST 30 PRESS RELEASES:

Hanbat National University researchers present new technique to boost solid oxide fuel cell performance

Even short school breaks affect student learning unevenly across socioeconomic backgrounds

When words matter: Language and culture shape early childhood outcomes

UBC enzyme technology clears first human test toward universal donor organs for transplantation

Birds’ vocal warnings provide new insight into the origins of language

Breakthrough results from elephant herpesvirus trial find vaccine to be safe

Final step in the biosynthesis of iridoids elucidated

New antibiotic targets IBD — and AI predicted how it would work before scientists could prove it

Glioblastomas affect much more than just the brain

Researchers uncover why mental maps fade with age

New mechanism revealed: How leukemia cells trick the immune system

Genetic map reveals influence of DNA on metabolism

Researchers use ultrasound holograms to influence brain networks

Unique videos show how trawling restrictions brings back life to the sea

Whooping cough can be fatal in young infants, experts warn

Knee-d for excellence: New regional training hub keeps surgeons sharp for ageing population

The Lancet: Billions lack access to healthy diets as food systems drive climate and health crises, but sustainable, equitable solutions are within reach, says new EAT-Lancet report

Countries with highest reported levels of hearing loss have lowest use of hearing aids

Early medical abortion at home up to 12 weeks is safe, effective, and comparable to hospital care

New approach to gravitational wave detection opens the Milli-Hz Frontier

Rice membrane extracts lithium from brines with greater speed, less waste

Exercise lowers disease risk. This researcher wants to understand how

Hurricane evacuation patterns differ based on where the storm hits

Stem Cell Reports welcomes new members to its Editorial Board

Researchers develop molecular qubits that communicate at telecom frequencies

Mayo Clinic awarded up to $40 million by ARPA-H for pioneering air safety research

People with Down syndrome have early neuroinflammation

CNIO researchers create the “human repairome”, a catalogue of DNA “scars” that will help define personalized cancer treatments

Strengthening biosecurity screening for genes that encode proteins of concern

Global wildfire disasters are growing in frequency and cost

[Press-News.org] Protein Aurora-A is found to be associated with survival in head and neck cancer
Fox Chase scientists suggest that the findings could also serve as a new target for treatment